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Abstract 17 
Enteric infectious disease in weaner piglets, including postweaning diarrhoea (PWD), are 18 
usually treated and/or prevented with antibiotics and/or zinc oxide in the piglet feed. 19 
However extensive use of antibiotics and zinc oxide in intensive animal production is 20 
unwanted as it may promote microbial antibiotic resistance and pose environmental 21 
problems. Recently, in an experimental model of PWD, we observed that oral 22 
administration of purified porcine immunoglobulin G (ppIgG) from pooled natural pig 23 
plasma could reduce enteric infection. In the present study we were able to reproduce 24 
these results as it was observed that oral ppIgG accelerated clearance of faecal 25 
haemolytic bacteria in pigs challenged with E. coli in comparison with pigs not receiving 26 
ppIgG. This effect was observed upon feeding ppIgG for seven days postweaning 27 
suggesting that ppIgG does not have to be used prophylactically for several days 28 
preweaning. Furthermore, the effect of oral administration of ppIgG for seven days 29 
postweaning was equal to or better than that of dietary zinc oxide in reducing diarrhoea 30 
symptoms and in clearing faecal haemolytic bacteria for 14 days postweaning. These 31 
observations warrant future trials of dietary ppIgG in intensive swine production units to 32 
establish its performance as an alternative to dietary antibiotics and zinc oxide for 33 
preventing PWD. 34 
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 38 
1. Introduction 39 
After parturition, lactogenic immunity provides offspring with oro-gastric protection 40 
against infectious pathogens (Hedegaard and Heegaard, 2016). In the conventional 41 
swine production systems piglets are weaned at an immunologically immature age (3–4 42 
weeks) depriving them of the continued supply of protective lactogenic antibodies at the 43 
same time as they are placed in a new environment with increased risk of enteric 44 
bacterial infections that may lead to postweaning diarrhoea (PWD) (Madec et al., 1998). 45 
PWD is characterised by diarrhoea caused by enteric infection by Enterotoxigenic 46 
Escherichia coli (ETEC) usually within three days postweaning ( Fairbrother et al., 2005). 47 
PWD, like other enteric infections in pigs, can be treated with dietary antibiotics 48 
(primarily tetracyclines, penicillins and macrolides ( Becker, 2010; DANMAP, 2015 ;  49 
Wageningen University, 2012)), and/or zinc oxide (Pluske, 2013). Indeed, antibiotics and 50 
zinc can improve average daily growth (ADG) in weaner piglets ( Cromwell, 2002 ;  Molist 51 
et al., 2011), and dietary zinc can reduce frequency of PWD in weaner piglets ( Owusu-52 
Asiedu et al., 2003 ;  Pluske, 2013). The mechanisms by which zinc oxide increases ADG 53 
and reduces diarrhoea in weaner piglets are not fully understood but seem to involve 54 
both restoring plasma zinc levels to normal in piglets after weaning (Davin et al., 2013) 55 
and improving intestinal homeostasis ( Liu et al., 2014a; Liu et al., 2014b ;  Shen et al., 56 
2014). 57 
However, the widespread use of dietary zinc oxide in intensive animal production can 58 
result in pollution of farmlands and groundwater through repeated fertilisation with 59 
zinc-containing residual manure (Hill et al., 2005). In addition, zinc oxide in combination 60 
with antibiotics appears to accelerate microbial antibiotic resistance by increasing the 61 
rate of the exchange of antibiotic-resistance-gene containing plasmids in the microbiota 62 
community in both soil and piglet intestines (Lin et al., 2016; Pal et al., 2015 ;  Vahjen et 63 
al., 2015); thus, there is a need to reduce both kinds of interventions. 64 
As a sustainable and economically feasible alternative to antibiotics and zinc for treating 65 
PWD, we have previously investigated the use of natural purified porcine 66 
immunoglobulin G (ppIgG) from pooled abattoir blood plasma (Hedegaard et al., 2016). 67 
First, it was established that natural ppIgG does indeed contain immunoglobulin 68 
dependent anti-E. coli activity. Secondly it was shown that a dietary ppIgG supplement 69 
in a model of PWD led to faster clearance of an ETEC challenge infection than seen in a 70 
comparable control group not provided with dietary ppIgG ( Hedegaard et al., 2016). 71 
This prompted us to further investigate this effect of ppIgG in E.coli challenge models. A 72 
long term, low ppIgG dose experiment and a short term, high ppIgG dose experiment 73 
were performed. In both experiments dietary ppIgG resulted in reduction of diarrhoea 74 
and in number of faecal haemolytic bacteria; moreover, in the second trial we observed 75 
that ppIgG reduced diarrhoea and cleared the enteric infection faster than dietary zinc 76 
oxide. These observations warrant future experiments investigating the use of dietary 77 
ppIgG postweaning as an alternative to dietary zinc oxide and antibiotics in 78 
treating/preventing PWD. 79 
 80 
2. Materials & methods 81 
The study comprised two infection experiments, both using E. coli O149 challenge at 82 
two consecutive days post weaning. In experiment 1 (long term, low IgG dose pilot 83 
study) 750 mg/day of ppIgG was provided orally for five days before and 10 days post 84 
weaning. In experiment 2 (short term, high IgG dose) 1.9 g of ppIgG was given orally 85 
twice daily for seven days after weaning/challenge. Experiment 2 also comprised a 86 
group receiving dietary zinc oxide for 10 days after weaning. 87 
 88 
2.1. Purified porcine immunoglobulin G (ppIgG) 89 
The ppIgG was prepared from pooled pig plasma by expanded bed chromatography 90 
(EBA) at Upfront Chromatography A/S (Copenhagen), as described previously 91 
(Hedegaard et al., 2016). Concentrated porcine blood plasma was obtained from Daka 92 
SARVAL A/S (Lunderskov, Denmark). The batch of ppIgG used in first experiment 93 
(experiment 1, see below) was the same as in (Hedegaard et al., 2016), whereas a new 94 
batch of ppIgG was prepared prior to the second (experiment 2, see below). 95 
 96 
2.2. ELISA 97 
The IgG concentration in the batches of ppIgG was measured by a sandwich ELISA 98 
(Hedegaard et al., manuscript in preparation), utilising a goat anti-pig IgG (Fc) antibody 99 
(AAI41, Nordic Biosite ApS, Copenhagen) both for capture and detection. The IgG-100 
concentration of ppIgG used in experiment 1 was 37.5 mg/ml and in experiment 2 the 101 
ppIgG concentration was 75 mg/ml. 102 
Anti-E. coli activity was found in both batches of ppIgG, used in this study, by indirect 103 
whole-E. coli cell ELISA previously reported ( Hedegaard et al., 2016); briefly 96 wells flat 104 
bottom microtiter plates (Maxisorp, NUNC, Thermo Scientific, Denmark) were coated 105 
with 100 μl fixed E. coli O138 (in-house strain isolated from piglet with diarrhoea) in 0.1 106 
M sodium carbonate buffer pH 9.6 (OD546 = 0.25) at 4 °C overnight. All subsequent 107 
operations were performed at room temperature. Next day wells were washed four 108 
times in PBS with 0.05% Tween 20 (PBS-T), and blocked with 200 μl PBS-T with 1% 109 
bovine serum albumin (BSA; Sigma-Aldrich, Brøndby, Denmark) for 30 min when shaking 110 
then followed by four times wash as above. The ppIgG was added in 2-fold dilution 111 
series (diluted in PBS-T 1% BSA from 10 to 0.02 mg/ml). After 1 h of incubation with 112 
shaking and 4 washes in PBS-T, detection antibody HRP-conjugated goat anti-pig IgG 113 
(GGHL-5P; ICL, SMS Gruppen; Rungsted, Denmark) diluted 1/2000 in PBS-T 1% BSA was 114 
added and incubated for 1 h with shaking. After washing, plates were developed by TMB 115 
Plus substrate (Kem-En-Tec, Taastrup, Denmark), 100 μl/well, and stopping colour 116 
development by 100 μl/well 0.5 M H2SO4 (VWR—Bie & Berntsen A/S). Optical density 117 
was measured by a Thermo Scientific Multiscan EX microplate reader at 450 nm 118 
subtracting background absorbance at 650 nm. 119 
Using the antigen specific ELISA it was found that the ppIgG batch used in experiment 1 120 
had lost 14% of activity in comparison to the original plasma pool, whereas the batch 121 
used in experiment 2 had lost no activity (data not shown). 122 
 123 
2.3. Experiments 124 
2.3.1. Experimental procedure 125 
Two separate factorial experiments at Aarhus University, Foulum, involving 12 (10.8 ± 126 
1.8 kg BW, from 2 litters) and 18 (7.3 ± 1.0 kg BW, from 2 litters) pigs for the first and 127 
second experiments, respectively, were conducted (see Table 1). In both experiments, 128 
piglets were weaned from sows that had been tested to be homozygote carriers of the 129 
dominant gene encoding for intestinal F4 fimbriae receptors (Van Haeringen 130 
Laboratorium, b.v., Wageningen, The Netherlands) on DNA extracted from hair sample. 131 
Piglets were weaned from the sows at day 28 of age, and were challenged with E. coli 132 
O149:F4 on two consecutive days (d 29 and 30 of age). Within each experiment, piglets 133 
from different litters were equally distributed among treatments. 134 
In the first experiment, half of the piglets (Table 1; Exp. 1, Group 1 + 2) received once 135 
daily for 15 days (5 days preweaning and 10 days postweaning) 20 ml (750 mg) of ppIgG, 136 
provided by a 20 ml syringe; a small plastic tube was connected to the syringe and the 137 
ppIgG was slowly dipped in and piglets willingly lapped up, ensuring that no ppIgG was 138 
lost. 139 
The other half of the pigs received 20 ml 0.9% NaCl (Table 1; Exp. 1, Group 3 + 4). Pigs 140 
were provided the immunoglobulin product before feeding. 141 
In the second experiment, pigs were allotted into three challenge-groups (Table 1; lower 142 
part): two groups received no immunoglobulins but piglets were provided with 25 ml of 143 
0.9% NaCl and provision of feed (from day of weaning) based on wheat, barley and 144 
dehulled soybean, and with either 2500 ppm zinc oxide (Hammershøj Pharmacy, 145 
Hammershøj, Denmark) for 14 days postweaning (Table 1; Exp. 2, Group 1), or no zinc 146 
oxide (Table 1; Exp. 2, Group 2). The third group received ppIgG via 20 ml syringe on the 147 
morning before weaning (day 27), and on the morning of weaning (day 28). The ppIgG 148 
feeding was continued twice daily by drench gun for 7 days postweaning with a 149 
provision of 25 ml (1.9 g) of ppIgG twice daily (Table 1; Exp. 2, Group 3). 150 
 151 
The animal experiment was conducted according to the personal license (Charlotte 152 
Lauridsen, J. nr. 2012-15-2934-00125) obtained by the Danish Animal Experiments 153 
Inspectorate, Ministry of Food, Agriculture and Fisheries, Danish Veterinary and Food 154 
Administration, and animals were followed by proper veterinary surveillance throughout 155 
the experiment. 156 
 157 
2.3.2. Animals, feeding and housing 158 
All piglets were tested susceptible to E. coli O149:F4 by using a DNA marker genotyping-159 
based test (van Haeringen laboratorium b.v., Wageningen, The Netherlands) on DNA 160 
extracted from hair samples. From weaning and onwards, the pigs had ad libitum access 161 
to feed and water. The feed was a standard diet for weaners prepared at the facilities at 162 
Aarhus University, Foulum. Two littermates of similar weight were housed in pairs in 163 
1.45 m × 1.7 m pens with concrete flooring and sawdust bedding. In experiment 1, the 164 
unchallenged (Groups 1 + 3) and challenged pigs (Groups 2 + 4) were housed in different 165 
rooms to avoid cross contamination with the challenge E. coli strain. A door separated 166 
the rooms between the challenged and unchallenged piglets, and personnel changed 167 
clothes/shoes before entering any of the rooms. Environmental conditions including 168 
temperature (∼24 °C), humidity (∼50%) and bedding (sawdust) were similar in the two 169 
rooms. Experiment 2 was conducted in the same rooms, but all pigs were challenged 170 
with E. coli, and there was free passage between the rooms throughout the entire 171 
experiment. 172 
 173 
2.3.2.1. E. coli challenge 174 
In both experiments, pigs were orally inoculated with 1.0 × 109 colony-forming units 175 
(cfu) of E. coli O149:F4 in 5 ml 0.9% NaCl on day 1 and 2 after weaning (day 0 was the 176 
day of weaning) using a syringe. After inoculation, the tube was flushed with 177 
approximately 10 ml 10% NaHCO3 in order to neutralize gastric acid and increase the 178 
survival rate of the challenge strain in the stomach, and to ascertain that all the E. coli 179 
suspension had been given to the piglets. The control pigs (exp. 1) received equivalent 180 
amounts (approximately 5 ml) of 0.9% NaCl and 10 ml 10% NaHCO3 in order to obtain 181 
an equal level of stress associated with the oral inoculation as for the challenge 182 
treatment. 183 
 184 
2.3.3. Performance and diarrhoea assessment 185 
Diarrhoea assessment was based on the consistency of the faeces (1 = hard, dry and 186 
cloddy, 2 = firm, 3 = soft with shape, 4 = soft and liquid, 5 = watery and dark, 6 = watery 187 
and yellow, 7 = foamy and yellow) from the day prior to challenge until 7 days after. A 188 
faecal consistency score >3 was defined as a clinical sign of diarrhoea (Carstensen et al., 189 
2005). Before the E. coli challenge, and on day 2 after challenge, and daily until day 5 190 
after challenge, and thereafter every second day during the second week after weaning, 191 
faecal samples were collected from the rectum of the pigs and 1 g faeces was suspended 192 
in a (1:10, wt/wt) peptone solution and homogenized by bag mixer (BagMixer100, 193 
Interscience, St. Nom, France). Serial dilutions of the slurry were done prior to 194 
enumeration of haemolytic E. coli on blood agar (BA; Oxoid) after aerobic incubation at 195 
37 °C overnight. From each BA plate, five haemolytic E. coli colonies were selected and 196 
tested for O149 and O138 type reactions by O-seroagglutination (Statens Serum Institut, 197 
Copenhagen, Denmark). In addition, faecal samples were analysed for dry matter by 198 
freeze-drying (ScanVac Coolsafe 55, Labogene Aps, Lynge, Denmark). 199 
Feed intake was recorded daily for each pen and body weight of the pigs was recorded 200 
at the beginning and weekly thereafter until the end of the experiment. Average daily 201 
feed intake (ADFI) and gain (ADG) were determined based on pen by dividing the total 202 
feed intake or total weight gain of pigs in each pen by days of feeding. 203 
 204 
2.4. Statistics 205 
The effects of ppIgG, dietary zinc oxide or no treatment for seven days postweaning on 206 
diarrhoea symptoms and bacterial count in both experiments were statistically analysed 207 
using either Mann-Whitney test or Two-way ANOVA followed by Tukey’s post-test, in 208 
GraphPad Prism version 7.00 for Windows, GraphPad Software, La Jolla California USA,  209 
www.graphpad.com. 210 
 211 
3. Results and discussion 212 
In this study we performed two infection experiments using an E. coli O149 challenge 213 
strain at both day one and two after weaning. The administration of ppIgG was different 214 
in the two experiments: In experiment 1, 750 mg of ppIgG was provided orally once daily 215 
prophylactically for five days preweaning and then 10 days postweaning, whereas in 216 
experiment 2, 1.9 g of ppIgG was administered orally twice daily for seven days 217 
postweaning. Two different ppIgG batches were used for the two experiments, for 218 
experiment 1 a 37.5 mg/ml batch and for experiment 2 a 75 mg/ml batch. 219 
 220 
3.1. Disease 221 
In both experiments diarrhoea was observed within one day after inoculation due to the 222 
O149 ETEC challenge as observed by faecal scoring (Fig. 1A + B) and faecal dry matter 223 
measurement (Fig. 1C + D). We observed in both experiments that the +ppIgG 224 
+challenge group (group 2 in exp. 1 and group 3 in exp. 2) had, at day five, significantly 225 
less diarrhoea as compared to the control challenge groups (group 4 in exp. 1 and group 226 
2 in exp. 2) that were not provided with ppIgG as observed by a lower faecal scoring and 227 
a higher percentage of faecal dry matter (p < 0.03; Fig. 1, days 1–5). In experiment 1 the 228 
O149 ETEC challenge strain began to cease at day 7, however an unintended enteral 229 
infection, starting around day 5–7 after weaning and lasting the remainder of the study 230 
period was observed (Fig. 1A + C, days 5–21), coinciding with the appearance of an O138 231 
ETEC strain in faeces (detected by PCR; data not shown). The presence of this 232 
unintended infection somewhat obscured experiment 1, however the data from day 0 to 233 
five were promising and prompted us to conduct a second experiment in which the daily 234 
IgG dose was quadrupled but then only provided seven days post weaning. This batch of 235 
ppIgG had an IgG concentration of 75 mg/ml, and was administered twice daily, 236 
amounting to a daily dose of 3.8 g. 237 
Experiment 2 proceeded without any unintended infection, and group 3 (+ppIgG 238 
+challenge group) had significantly less diarrhoea than both group 1 and 2 (+zinc 239 
+challenge and no treatment groups) within the first week after weaning (p < 0.02 Two-240 
way ANOVA; Fig. 1B + D); demonstrating that ppIgG significantly reduced diarrhoea in 241 
the PWD model within the first week post weaning to the same level or lower than 242 
dietary zinc. 243 
Moreover, our results indicate that it is not necessary to use ppIgG prophylactically for 244 
several days preweaning as there was a clear effect of ppIgG in experiment 2 on 245 
diarrhoea without the five days preweaning ppIgG treatment applied in experiment 1 246 
(Fig. 1). This also corroborates a previous study (Hedegaard et al., 2016) where ppIgG 247 
was mixed into the feed that was only available from weaning and decreased 248 
diarrhoeagenic Enterobacteriaceae in comparison to a non-ppIgG diet. Also, it has been 249 
shown (Foged et al., 1986) that monoclonal anti-E. coli F4 fimbriae antibodies 250 
administered at as well as after challenge, but not prophylactically, protected neonatal 251 
piglets from an otherwise lethal challenge with F4+ ETEC. On the other hand, it seems to 252 
be important to maintain a high administration frequency and an adequately high 253 
antibody dose for limiting diarrhoea. 254 
 255 
3.2. Microbiology 256 
In both experiments ppIgG helped clear the challenge strain within one week of 257 
challenge (Fig. 2, days 1–7). However, as noted above, all groups in experiment 1 258 
experienced an unintended O138 ETEC infection from day 4–9, as seen by an increase in 259 
numbers of faecal haemolytic bacteria (Fig. 2A, days 4 + 7 + 9). Group 1 (+ppIgG no 260 
challenge) experienced this infection at day 4 while it was observed in group 2 (+ppIgG 261 
+challenge) on day 9. Thus, the daily administration of 750 mg of natural IgGs did not 262 
provide protection against the unintended infection in neither of the two +ppIgG groups 263 
(Fig. 2A, groups 1 + 2, days 4–21), even though in vitro data support that ppIgG binds to 264 
O138 (and O149) ETEC and can inhibit their adhesion to intestinal epithelial cells in vitro 265 
( Hedegaard et al., 2016). This might indicate that the unintended infection was 266 
multifactorial, and/or that the daily dose of 750 mg natural ppIgG used in this 267 
experiment was not adequate to prevent this type of infection. Data from dose-268 
response field trials are needed before any further conclusions can be made on this 269 
matter. 270 
In experiment 2, only infection with the challenge-strain was observed. Confirming 271 
previous results (Hedegaard et al., 2016), ppIgG caused a faster clearance of 272 
diarrhoeagenic (haemolytic) bacteria in group 3 than was observed in the other two 273 
groups (Fig. 2B). Thus day 7 was the last day on which faecal haemolytic bacteria were 274 
detected in group 3 (+ppIgG), while these bacteria could still be detected on day 9 in 275 
group 1 (+zinc group), and in group 2 (control) one piglet still had faecal haemolytic 276 
bacteria on day 15 (Fig. 2B). Taken together, ppIgG appears to intervene with the 277 
colonization by the ETEC challenge strain shortening the period of infection significantly 278 
(Fig. 2B, Day 5, p < 0.02) and was as efficient as dietary zinc in reducing the infection 279 
with the ETEC challenge strain. Although this suggests that ppIgG can shorten the 280 
duration of diarrhoea in weaner piglets by decreasing the number of faecal 281 
diarrhoeagenic haemolytic bacteria, this should ideally take place without a perturbing 282 
the composition of the normal intestinal microbiota. In experiment 1, no change in the 283 
faecal non-haemolytic bacteria were initially observed (Fig. 2C, days 1–5) however, as 284 
the unintended infection emerged the number of faecal non-haemolytic bacteria began 285 
decreasing (Fig. 2C, days 7–21). In group 2 (+ppIgG +challenge) the faecal non-286 
haemolytic bacteria actually were not recovered for 3 days at the height of the 287 
unintended infection (Fig. 2C, days 11–14), which coincided with the termination of 288 
administration of ppIgG. However in experiment 2, no changes in the count of faecal 289 
non-haemolytic bacteria in any of the three other groups were observed (Figs. 2D), 290 
indicating that ppIgG does not intervene with the intestinal non-haemolytic commensal 291 
microbiota and that the microbiota changes observed in experiment 1 was probably due 292 
to the unintended infection. These observations are supported by preliminary next 293 
generation sequencing data on the faecal microbiota composition of piglets fed ppIgG 294 
showing no change in non-haemolytic commensals (unpublished data). 295 
Disease (diarrhoea) frequency, growth and feed conversion are primary end points for 296 
swine producers however the two experiments described here comprised low numbers 297 
of piglets (n = 12/18) and pens (n = 4/3) making it very difficult to analyse growth data 298 
statistically. Also, the data on growth and feed intake showed a very large pig-to-pig 299 
variation. For example, in experiment 2 half of the piglets in group 3 (+ppIgG), for 300 
unknown reasons, became anorexic during the third week resulting in almost no weight 301 
gain for the group. Therefore it will be interesting to observe how ppIgG 302 
supplementation will influence disease resistance, growth and feed conversion in field 303 
trials incorporating an adequate number of pigs to allow for appropriate statistical data 304 
analysis to be performed. In spite of being a small preliminary study the results shown 305 
here do however demonstrate the ability of dietary ppIgG to clear an enteric ETEC 306 
infection and thus ppIgG could be used as an alternative to dietary zinc. 307 
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Tables 454 
Table 1: Study setup 455 
Experiment 1 Group 1 
+ppIgG 
Group 2 
+ppIgG+E.coli 
Group 3 
Control 
Group 4 
+E.coli 
Number of piglets 3 3 3 3 
E. coli F4+ challenge No Yes No Yes 
750 mg ppIgG (20 ml) Yes Yes No No 
20 ml 0.9%  NaCl solution No No Yes Yes 
Avg. weight at weaning 
(kg) 
11.2±3.1 10.6±1.7 10.4±1.9 11.0±1.2 
Experiment 2 Group 1 
+ E.coli +Zn 
Group 2 
+E.coli 
Group 3 
+E.coli +ppIgG 
 
Number of piglets 6 6 6 (5)1 
E. coli F4+ challenge Yes Yes Yes 
2x1.9 g ppIgG (2x25 ml) No No Yes 
25 ml 0.9% NaCl solution Yes Yes No 
Zinc oxide in feed Yes No No 
Avg. weight at weaning 
(kg) 
6.9±1.1 7.9±0.9 7.0±0.9 
1 One piglet was euthanized on day 3 post infection due to serious illness. 456 
 457 
 458 
Figure legends 459 
Figure 1. Faecal analysis: Faecal diarrhoea score (A+B) and faecal dry matter (C+D); () 460 
no treatment, no E. coli; () no treatment, +E. coli: (--) +ppIgG, no E. coli; ()ppIgG 461 
treatment, +E. coli; () dietary zinc, +E. coli. Each data point is plotted and curves 462 
outline the mean for each group. Vertical dotted line indicates the last day of ppIgG 463 
administration. Pairwise comparisons between groups on each day were tested for 464 
statistical significance using Mann-Whitney test: a = IgG vs. Zinc (p<0.03); b = IgG vs. 465 
Control (p<0.03); c = IgG vs. Zinc (p<0.02); d = IgG vs. Control (p<0.01); e = Zinc vs. 466 
Control (p<0.02). 467 
 468 
 469 
Figure 2. Faecal bacterial analysis: Content (CFU/ml) of haemolytic bacteria (A+B) and 470 
non-haemolytical bacteria (C+D). Symbols as for Figure 1. Each data point is plotted and 471 
curves outline the mean for each group. Vertical dotted line indicates the last day of 472 
ppIgG administration. Pairwise comparisons between groups on each day were tested 473 
for statistical significance using Mann-Whitney test: a = IgG vs. control (p<0.02). 474 
 475 
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 477 
 478 
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